|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00241 ALI HEALTH
Nominal 
5.250 +0.010 (+0.191%) Ranking Overview
Ranking based on 7 research report(s)
Average Ranking 2.29
|
Strong Buy (1)
0
|
Buy (2)
5
|
Hold (3)
2
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 03/2024 | EPS | 6.29 RMB (cts) | |
| Net Profit | 883.48 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 1,576.00 | 11.00 | 0 | -- | 2,055.00 | 1,552.00 |
| 2026 | 2,210.00 | 15.00 | 0 | -- | 2,361.00 | 1,931.00 |
| 2027 | 2,663.00 | 17.50 | 0 | -- | 3,160.54 | 2,261.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 1,792.70 | 11.00 | -- | HSBC | Buy | 5.50 | 27/03/2025 | |
| 2025 | 1,564.00 | 12.00 | -- | HAITONG | OutPerform | 5.42 | 25/11/2024 | |
| 2025 | 1,570.00 | 9.80 | -- | BANK OF AMERICA | Buy | 5.20 | 14/04/2025 | |
| 2025 | 1,576.00 | 10.00 | -- | MORGAN STANLEY | Overweight | 5.00 | 21/11/2024 | |
| 2025 | 1,552.00 | 10.00 | -- | CITIC SEC | ADD | 4.30 | 27/11/2024 | |
| 2025 | 1,891.00 | 13.00 | -- | GOLDMAN SACHS | Neutral | 4.00 | 27/11/2024 | |
| 2025 | 2,055.00 | 13.00 | -- | UBS | Neutral | 3.75 | 28/11/2024 | |
| 2026 | 2,349.93 | 15.00 | -- | HSBC | -- | -- | 27/03/2025 | |
| 2026 | 1,981.00 | 15.00 | -- | HAITONG | -- | -- | 25/11/2024 | |
| 2026 | 2,156.00 | 13.40 | -- | BANK OF AMERICA | -- | -- | 14/04/2025 | |
| 2026 | 2,210.00 | 14.00 | -- | MORGAN STANLEY | -- | -- | 21/11/2024 | |
| 2026 | 1,931.00 | 12.00 | -- | CITIC SEC | -- | -- | 27/11/2024 | |
| 2026 | 2,298.00 | 16.00 | -- | GOLDMAN SACHS | -- | -- | 27/11/2024 | |
| 2026 | 2,361.00 | 15.00 | -- | UBS | -- | -- | 28/11/2024 | |
| 2027 | 3,160.54 | 20.00 | -- | HSBC | -- | -- | 27/03/2025 | |
| 2027 | 2,635.00 | 16.40 | -- | BANK OF AMERICA | -- | -- | 14/04/2025 | |
| 2027 | 2,884.00 | 18.00 | -- | MORGAN STANLEY | -- | -- | 21/11/2024 | |
| 2027 | 2,261.00 | 14.00 | -- | CITIC SEC | -- | -- | 27/11/2024 | |
| 2027 | 2,616.00 | 18.00 | -- | GOLDMAN SACHS | -- | -- | 27/11/2024 | |
| 2027 | 2,691.00 | 17.00 | -- | UBS | -- | -- | 28/11/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 16/05/2025 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 768,953 |
| %Change | 72.453% |
| EPS / (LPS) | RMB 0.048 |
| NBV Per Share (¥) | RMB 0.949 |